A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease - Test2 - elhamkhani - TriplyDB

A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease

A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease

http://www.wikidata.org/entity/Q28361892

about

Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations Nitric oxide and peroxynitrite in health and disease Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.The balance of powers: Redox regulation of fibrogenic pathways in kidney injury Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review Advances in diabetes for the millennium: vitamins and oxidant stress in diabetes and its complications Acute hyperglycemia induces an oxidative stress in healthy subjects Oxysterol and diabetes activate STAT3 and control endothelial expression of profilin-1 via OSBP1 The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.Oxygen, oxidative stress, hypoxia, and heart failure.Oxidation of cellular amino acid pools leads to cytotoxic mistranslation of the genetic code Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.Vitamin C as an antioxidant: evaluation of its role in disease prevention.Transition metals redox: reviving an old plot for diabetic vascular disease.Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes Quantitative analysis of amino Acid oxidation markers by tandem mass spectrometry Carbonyl stress and diabetic complications.Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.Cardiovascular redox and ox stress proteomics.Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.Old world nonhuman primate models of type 2 diabetes mellitus.Roles of the tyrosine isomers meta-tyrosine and ortho-tyrosine in oxidative stress.Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA).Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.Decreased nitric oxide bioavailability in a mouse model of Fabry disease.Postprandial hyperglycemia as an etiological factor in vascular failure The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis.EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease.Short-term hyperglycemia increases arterial superoxide production and iron dysregulation in atherosclerotic monkeys Glycosylated human oxyhaemoglobin activates nuclear factor-kappaB and activator protein-1 in cultured human aortic smooth muscle.Misincorporation of free m-tyrosine into cellular proteins: a potential cytotoxic mechanism for oxidized amino acids.Oxidative damage to proteins in yeast cells exposed to adaptive levels of H(2)O(2).

P2860

Q23912644-AD74B1EB-B043-4249-B9ED-F4DB92D74E4D Q24645400-E8164494-E412-414A-87EC-9E359D397B50 Q24656109-362D9BEE-0841-4E2E-978D-14488D01D73F Q24796491-B35B9433-7F9B-4E37-BF62-49739CB898AF Q26786137-46B4A979-3289-4C31-8AB0-4F6F0F4CB49C Q28072656-6EB15E7C-FB9E-4AF3-83B2-ECF22A397584 Q28213075-6B875BF4-A809-4E3C-8D3E-09B02E088169 Q28346605-E5F9FD99-C5D2-479B-BE2E-A48E1EF2DDA6 Q28571298-EFFF0A8E-7236-475D-A9D0-DDCFC5688CF7 Q30426517-8F9B7AEB-3ED6-436A-8216-770912A8D266 Q30428077-A995101B-99F6-4DA0-9BA2-98BD19859F95 Q33220108-F2439083-3E8A-4675-8807-5A954354AAD7 Q33683779-9BAC26F4-35F4-4085-91E1-15778BAD9EB7 Q33789736-FD7B6D22-0E01-422B-89C7-5E4532971423 Q33849720-C9195647-F06E-467A-B340-4A4E7197826B Q33922502-1DD7DE4D-C2CE-4EC2-8DB1-6333D766581C Q34175262-7F333A58-1F55-4C3E-9F08-4A4737901C22 Q34206401-D3C0D533-D995-481D-82A0-F918A725927C Q34427577-4C7E7107-CC4E-4105-A888-D6DDB24FE90C Q35047134-22F4E030-CF09-4B9C-9585-432F3D53E466 Q35140825-E0E50F86-695F-4949-B9B3-C69AC2099A68 Q35173711-4D73EB19-C9A5-45B2-B014-A5ECDD95F2E8 Q35576070-65CA1610-E3BA-4B26-B9A4-D29352D542FF Q35993115-F68B74AE-C287-4FCC-80E3-26589C764AB8 Q36252927-F3712B8F-DAC6-49E6-A331-6DA9653FD095 Q36398989-BB352EE4-FA40-4F6E-B2B5-249AB97C3C8D Q36521117-90530FC6-DEE5-4FE6-83AA-C91C15839497 Q36826913-3C6C53E4-EEC4-43FC-8F6E-37ACFBDCB4E1 Q37141711-2F8963FC-FCA1-4C11-97C4-28B343E83BEE Q37172727-DE3AA80C-7311-4D8E-B85D-AB4094CFB9BF Q37330561-31157E3F-A6FB-4459-9767-4BE7B05A8501 Q37464262-0FAFBAD3-EB04-4228-A980-A0596EDCE360 Q37512515-86A8E255-1469-4E1C-B585-AEE0D25FDDD2 Q37643127-17E1845F-6421-40B2-A1F7-C01D442E0A5E Q38585738-5CB53C01-6602-4A00-861A-056EA3F11461 Q39552627-3300E6B8-4168-4358-BA95-E7F9EFD78FD0 Q41418368-6E3989E8-B433-4922-A149-10849CFAB823 Q41827463-4B54A899-DC02-4301-AC45-046C1D4DC505 Q43258177-585AD0C5-2517-4750-A366-33F2CCA3B6E4 Q44773990-4C171D67-28B4-4A3A-AFC5-03F974DEEA35

P2860

A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease

http://www.wikidata.org/entity/Q28361892

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@ast

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@en

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@nl

type

label

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@ast

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@en

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@nl

prefLabel

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@ast

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@en

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@nl

P1433

Q28361892-A8645337-C59D-48F9-A562-C086714A0DCD

P1476

Q28361892-FD481FD9-64EC-4573-AAD4-A459600DD182

P2093

Q28361892-133C21F0-93CF-49FA-B4ED-81C953DEF6CB

Q28361892-42E16DCB-6ADF-4CFC-A438-C9324F966DA7

Q28361892-520BA3B9-A672-417D-8F4E-5AEC8CA9E122

Q28361892-61347DDA-5B80-4E3E-BE3E-439C3698FF6A

Q28361892-A35C9CA7-B075-4281-92C7-27C3AB333295

P2860

Q28361892-0AA56F77-D669-4CF9-81C8-9575FCA3C51D

Q28361892-2DA6C23B-A206-46B0-A99F-D4DE9BFE896C

Q28361892-2E28CB88-3386-4A26-83C5-8486F7BB57C6

Q28361892-3198A4F0-90DC-418D-844B-C78408CEC08D

Q28361892-3399C505-1C98-4242-B576-69DF2E5B5C7A

Q28361892-442C59EA-E966-4CA2-85C2-83B41219A18B

Q28361892-467297C8-B2F2-4FD9-A328-1CAB3BCCE1FD

Q28361892-47802C75-D994-4371-8802-9FAD4322DDD7

Q28361892-4E6A5573-D956-4572-A7E4-8706048972A9

Q28361892-51970EB9-9405-4EB0-98B5-DE6C4F72CE5E

P304

Q28361892-27022021-71B2-48A1-9506-14C2C46F1AA5

P31

Q28361892-C4C2CB6F-1BCB-4074-BAF5-2CCE5EB4426E

P356

Q28361892-E2F14342-26A3-4DC1-9AAA-350895DF8A0C

P407

Q28361892-7FF1F616-44CE-4A43-A419-4CC194BFA5D3

P433

Q28361892-C50F738C-9C91-4758-AFD6-25D2BEF8750B

P478

Q28361892-2CD306EC-16FC-4D8E-B733-93CD0F266B18

P577

Q28361892-0BDB3333-2DC1-4AD5-9143-0C2C3515194F

P698

Q28361892-53BFB648-8BB8-48FE-841F-BBD96FE13915

P932

Q28361892-F6A9FE2D-6AD2-4B31-8EE4-428826DE62A4

P356

P1433

Journal of Clinical Investigation

P1476

A hydroxyl radical-like specie ...... arly diabetic vascular disease

@en

P2093

C Leeuwenburgh

http://www.w3.org/2001/XMLSchema#string

J D Wagner

http://www.w3.org/2001/XMLSchema#string

J W Heinecke

http://www.w3.org/2001/XMLSchema#string

K N Litwak

http://www.w3.org/2001/XMLSchema#string

S Pennathur

http://www.w3.org/2001/XMLSchema#string

P2860

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall.

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure.

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Advanced protein glycosylation in diabetes and aging.

P304

853-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI11194

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11285304

http://www.w3.org/2001/XMLSchema#string

P932

199570

http://www.w3.org/2001/XMLSchema#string